| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CHIASMA INC | 2,080,595 | 41,362,000 | 24.16% | ||
| 2 | Proteon Therapeutics | 2,017,872 | 27,423,000 | 16.02% | ||
| 3 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 24,701,000 | 14.43% | ||
| 4 | SIENTRA INC | 2,199,012 | 22,320,000 | 13.04% | ||
| 5 | LOMBARD MEDICAL INC | 3,473,452 | 12,331,000 | 7.20% | ||
| 6 | CEMPRA INC | 383,935 | 10,685,000 | 6.24% | ||
| 7 | Dicerna Pharmaceuticals | 945,757 | 7,755,000 | 4.53% | ||
| 8 | Innocoll | 555,555 | 6,689,000 | 3.91% | ||
| 9 | TOBIRA THERAPEUTICS INC | 589,244 | 5,657,000 | 3.30% | ||
| 10 | CymaBay Therapeutics | 1,600,000 | 3,072,000 | 1.79% | ||
| 11 | ANTHERA PHARMACEUTICALS I | 437,994 | 2,667,000 | 1.56% | ||
| 12 | REGULUS THERAPEUTICS INC | 327,350 | 2,138,000 | 1.25% | ||
| 13 | DERMIRA INC | 70,000 | 1,624,000 | 0.95% | ||
| 14 | OncoGenex Pharmaceuticals Inc | 603,740 | 1,334,000 | 0.78% | ||
| 15 | CHEMOCENTRYX INC | 215,000 | 1,296,000 | 0.76% | ||
| 16 | FLEX PHARMA INC COM | 10,000 | 120,000 | 0.07% | ||
| 17 | EPIRUS BIOPHARMA | 7,896 | 35,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011710, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
